Loading your page…
Marketing-authorisation holder · United States
4 medicines in 1 country, as authorisation holder.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| APONVIE32mg/4.4ml (7.2mg/ml) · Emulsion | Aprepitant | United States | Marketed | 2022 |
| CINVANTI130mg/18ml (7.2mg/ml) · Emulsion | Aprepitant | United States | Marketed | 2017 |
| SUSTOL10mg/0.4ml (10mg/0.4ml) · Injectable | Granisetron | United States | Marketed | 2016 |
| ZYNRELEF KIT200mg/7ml (29.25mg/ml); 6mg/7ml (0.88mg/ml) | 300mg/10.5ml (29.25mg/ml); 9mg/10.5ml (0.88mg/ml) | 400mg/14ml (29.25mg/ml); 12mg/14ml (0.88mg/ml) | 60mg/2.3ml (29.25mg/ml); 1.8mg/2.3ml (0.88mg/ml) · Solution, extended release | Bupivacaine, Meloxicam | United States | Marketed | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 4 | 4 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
